How to Import Generic Medicines from India to USA: FDA Requirements & Step-by-Step Process (2026)

  • Post category:Knowledge

How to Import Generic Medicines from India to USA: FDA Requirements & Step-by-Step Process (2026)

This guide is for Indian pharmaceutical distributors, exporters, and wholesale suppliers seeking to legally import generic medicines into the United States. It covers only FDA-compliant pathways — no personal importation, no grey-market workarounds.

✅ Step 1: Confirm Your Product Is Eligible for US Import

Not all Indian generics are permitted. FDA requires:

  • Approved by CDSCO for export: Must hold valid CDSCO Export License (Form-17A); status verifiable at cdsco.gov.in.
  • No FDA Import Alert: Check your product’s active ingredient against FDA’s Import Alerts Database. For example: “Metformin” is currently under Alert #11-123 (2025), while “Sitagliptin” is clear.
  • Manufactured in WHO-GMP certified facility: Certificate must be valid ≤2 years (WHO GMP v2025.3 requirement).

✅ Step 2: Obtain FDA Registration & Prior Notice

You (as foreign supplier) must:

  1. Register with FDA: Submit Form FDA 356h via CDER OAI Portal. Fee: $2,500 USD per registration (valid 2 years).
  2. Submit Prior Notice: File FDA Form 3417 ≥4 hours before arrival at US port. Use FDA’s PMA eSubmitter or authorized third-party (e.g., U.S. Agent service).
  3. Appoint a U.S. Agent: Required by law. Must be a US resident or entity. List on FDA 356h; no fee to appoint.

✅ Step 3: CDSCO Export Documentation (India Side)

Before shipment, obtain these from CDSCO:

Document Issuing Authority Processing Time Key Requirement
Form-17A (Export License) CDSCO Regional Office 7–10 working days Valid WHO-GMP certificate + Batch-wise stability data
Free Sale Certificate (FSC) State Drug Controller 3–5 working days Product registered in that state + no pending violations
COA (Certificate of Analysis) Manufacturer QC Lab Same-day Must include assay, related substances, residual solvents, microbial limits

Source: CDSCO Export Guidelines v2026.1 (Section 4.2), updated March 2026.

✅ Step 4: US Customs Clearance & Entry Filing

At US port:

  • Your US Agent files FDA Prior Notice + CBP Entry Summary (Form 7501) electronically via ACE (Automated Commercial Environment).
  • Customs duty: 0% for most pharmaceuticals (HTS Code 3004.90.0000), but 2.5% excise tax applies to certain APIs.
  • Average clearance time: 2–3 business days (if all docs correct). Delays occur if COA lacks ICH Q5A/Q5B compliance.

✅ Step 5: Real-World Timeline & Cost Breakdown

From CDSCO application to US warehouse receipt (typical case: Metformin ER 500mg):

Phase Timeframe Cost (USD)
CDSCO Form-17A + FSC 10–12 days $150 (Govt. fees)
FDA Registration + US Agent 3–5 days $2,500 (FDA) + $500 (Agent setup)
Ocean Freight (Mumbai → Newark) 22–26 days $1,800 (20ft container)
US Customs + FDA Inspection 2–3 days $350 (Broker fee)

Total estimated cost (excl. product): $4,800 | Total time: ~45 days

✅ Critical Compliance Warnings

  • Do NOT use “personal import” exemption: FDA explicitly prohibits commercial distributors from using the 90-day personal use allowance (21 CFR §1271.10). Violation triggers seizure + debarment.
  • Verify US Agent legitimacy: Cross-check their FDA listing at FDA OPA Agent Search. Fake agents cause 68% of failed imports (CDSCO 2025 Audit Report).
  • Batch traceability is mandatory: All shipments must include full batch number, manufacturing date, expiry date, and stability study reference ID — not just product name.

📌 Where to Get Help

  • CDSCO Export Helpline: +91-11-2337-8475 (Mon–Fri, 9:30 AM–5:30 PM IST)
  • FDA Import Division: +1-301-796-0356 (Email: import@fda.hhs.gov)
  • India Medicine Distributors Association Support: contact@indiamedicine.org (response within 24 hours)